Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

Advocates for lower drug prices say a federal lawsuit filed this month against St Louis-based Express Scripts and two other companies could result in more affordable medicine for patients. The Federal ...

Praluent has a list price of more than $14,000 a year. However, Express Scripts customers will be able to receive the drug for $4,500 to $6,600 annually after discounts and rebates, Express Scripts ...

Dec 8 (Reuters) - Short seller Citron Research's Andrew Left has turned his sights on Express Scripts Holding Co, calling the pharmacy benefit manager (PBM) the "culprit behind pharmaceutical price ...

Feb 4 (Reuters) - Cigna Corp's Express Scripts settled the U.S. Federal Trade ‌Commission's claims its insulin pricing practices violated antitrust and ‌consumer protection laws, and agreed to changes ...

Pharmacy benefit managers (PBMs) have used market leverage to demand rebates, which can lead drug manufacturers to increase sticker prices.

The nation's biggest pharmacy benefits manager is muscling back into the debate over soaring drug costs by promoting a less-expensive alternative to a life-saving medicine with a list price of $750 ...